Methods for increasing efficacy of FOLR1 cancer therapy
US11135305B2 · kind B2 · utility
3Cited by
26References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 9, 2017 |
| Grant date | Oct 5, 2021 |
| Priority date | — |
| Expiry date | Apr 17, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods to improve the success of cancer therapies that target the human folate receptor 1 are provided. Kits comprising reagent useful in the methods are further provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.